SSB
PCRX icon

Sandy Spring Bank’s Pacira BioSciences PCRX Stock Holding History

Sandy Spring Bank’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-300
Closed -$8.58K – 1281
2024
Q2 		$8.58K Hold
300
– – ﹤0.01% 894
2024
Q1 		$8.77K Buy
+300
New +$9.22K ﹤0.01% 869
2023
Q4 		– Sell
-185
Closed -$5.68K – 1211
2023
Q3 		$5.68K Hold
185
– – ﹤0.01% 910
2023
Q2 		$7.41K Hold
185
– – ﹤0.01% 896
2023
Q1 		$7.55K Hold
185
– – ﹤0.01% 871
2022
Q4 		$7.14K Hold
185
– – ﹤0.01% 871
2022
Q3 		$10K Hold
185
– – ﹤0.01% 806
2022
Q2 		$11K Buy
+185
New +$12.1K ﹤0.01% 821

Other funds holding PCRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Sandy Spring Bank's PCRX Position: Q3 2024 in Review

Sandy Spring Bank sold out of Pacira BioSciences (PCRX) in Q3 2024, closing a stake of 300 shares — an estimated $8.58K sold.

Sandy Spring Bank first reported a position in PCRX in Q2 2022 and held it in 8 quarters. The position peaked at $11K in Q2 2022. 239 funds tracked by Wall St. Rank hold PCRX as of Q3 2024.

  • Sandy Spring Bank reported no remaining Pacira BioSciences position as of Q3 2024 after selling out during the quarter.
  • Sandy Spring Bank sold 300 Pacira BioSciences shares in Q3 2024, an estimated $8.58K.
  • Sandy Spring Bank first reported a position in Pacira BioSciences in Q2 2022 and held it in 8 quarters.
  • Sandy Spring Bank's Pacira BioSciences position peaked at $11K in Q2 2022.
  • 239 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2024.

Based on Sandy Spring Bank's 13F filing for Q3 2024, filed 25 Oct 2024.